U.S. markets closed

Marrone Bio Innovations, Inc. (MBII)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.8789+0.0329 (+3.89%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
MACD

MACD

Previous Close0.8460
Open0.8423
Bid0.8383 x 1400
Ask0.9600 x 1800
Day's Range0.8128 - 0.8900
52 Week Range0.7700 - 2.9000
Volume1,605,447
Avg. Volume462,120
Market Cap154.936M
Beta (5Y Monthly)0.19
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Marrone Bio Innovations, Inc.
    FMC: Lowering target price to $101.00FMC CORP has an Investment Rating of HOLD; a target price of $101.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Medium.
    Rating
    Fair Value
    Economic Moat
    4 days agoArgus Research
View more
  • GlobeNewswire

    Marrone Bio Prepares to Submit Registration for Next-Generation Crop Protection Product in North America

    Company Also Looks to Expand Footprint in South America with Regulatory Submission of Bionematicide Seed Treatment, MBI-206, in BrazilDAVIS, Calif., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, is on track to submit MBI-306, its next generation nematicide/insecticide, to regulatory authorities in the United States within the coming weeks. Destined for row and specialty crop market

  • GlobeNewswire

    Marrone Bio Innovations, Inc. Reports Second-Quarter 2021 Financial Results

    DAVIS, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the second quarter ended June 30, 2021. Key results include: The net loss in the second quarter was $3 million, a 6% increase, and Adjusted EBITDA was a loss of $0.7 million, a 51% improvement. For the first half of 2021, net income (loss) and Adjusted EBITDA improved 36% and 63%, res

  • GlobeNewswire

    Marrone Bio Innovations Collaborates with Terramera to Enhance Product Performance and Expedite Novel Product Development

    Two global leaders in sustainable crop protection combine green technology and biological solutions to reduce agriculture’s environmental footprintDAVIS, Calif., Aug. 16, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII) (MBI or “Marrone Bio”), an international leader in sustainable bioprotection and plant health solutions to support global agricultural needs, and Terramera, a global agtech leader and inventor of Actigate™ technology, will collaborate to combine their technol